Septodont

OraVerse Local Anesthesia Reversal Agent. Box containing 1 blister of 10 x 1.7 OraVerse is the first and only local anesthesia reversal agent In clinical trials, the median time to recovery of normal sensation in the upper lip was 50 minutes for OraVerse patients vs. 133 minutes for the control group and in the lower lip was 70 minutes for OraVerse patients vs. 155 minutes for the control. In clinical trials, OraVerse patients were more quickly able to smile, speak, drink normally and minimize drooling. Market research shows 88% of patients may be interested in receiving a product like OraVerse1 Presentation Item #99210 – Box containing 1 blister of 10 x 1.7ml glass cartridges

Read more less

Indications Local dental anesthesia by infiltration or nerve block in adults and pediatric patients. Features & benefits Formulation without vaso-constrictor for specific clinical situations.  Fast onset: 30 to 120 seconds in the maxilla and 1 to 4 minutes for the mandible.  Duration: will ordinarily provide pulpal anesthesia of about 20 minutes in the maxilla, and about 40 minutes in the mandible.  No-methylparaben formulation to avoid allergic reactions on sensitive patients.  No natural rubber latex components to help reduce allergic responses.  Terminal sterilization of product/cartridges for safe use.  Mylar label covered glass cartridges to minimize risk of wound in the event of a cartridge breakage.  Cartridges packed 10 to a blister tray to avoid glass to glass contact, hence reducing breakage.  Ordering informationItem #01A1003 – Box containing 5 blisters of 10 x 1.7ml glass cartridges  Safety informationReactions to Scandonest® are characteristic of those associated with other amide-type local anesthetics. A major cause of adverse reactions to this group of drugs is excessive plasma levels, which may be due to overdosage, inadvertent intravascular injection or slow metabolic degradation. Scandonest® is contraindicated in patients with a known hypersensitivity to it or to any local anesthetic agent of the amide type or to other components of mepivacaine solutions. Local anesthetics should be employed only by clinicians who are well versed in diagnosis and management of dose-related toxicity and other acute emergencies which might arise from the block to be employed, and then only after insuring the immediate availability of oxygen, other resuscitative drugs, cardiopulmonary resuscitative equipment, and the personnel resources needed for proper management of toxic reactions and related emergencies. Scandonest® 2% L contains potassium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. Please see package insert for prescribing information.  

Read more less